Moderna walked a tightrope trying to convince shareholders it can both develop a new portfolio of drugs and keep costs down in the process.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
AI has a lot of promise in the healthcare industry in areas such as documentation, imaging, and quicker diagnostics as staffing shortages loom.
The Gym Group announced on Wednesday that in the first six months of this year it swung back to a profit for the first time since 2019.
With rising valuations, sports team ownership should be a slam dunk. But it’s also possible those valuations are a little rich.
Elliott Management ousted much of the board at Southwest Airlines, with Gary Kelly announcing his retirement amid broader board turnover.
Shares in major video game publisher Ubisoft took an over 7% hit on Monday after a minor investor’s letter.
On Monday, the Murdoch family was once again asked the $15 billion question: Who will take over the company after Rupert is no longer around?
While this could create a lucrative new revenue stream for Ford, it also presents a privacy conundrum, one expert said.
Boeing reached a tentative deal with the union representing its production workers in Washington state, likely dodging a strike.
American Transit Insurance Company (ATIC) insures over 60% of 117,000 taxis and for-hire vehicles. And it’s insolvent.
Some fans found that while they were waiting to buy Oasis tickets, the prices had quietly crept up from £135 ($177) to £350 ($460).
Days after Brent crude oil prices fell under $74 per barrel, the member nations of OPEC+ agreed to delay a production increase for two months.
Copyright issues make it difficult to substitute creative labor in game development, one expert said.
The Abu Dhabi National Oil Company (ADNOC) signed a deal with Exxon to buy a 35% share of a new hydrogen plant just outside Houston, Texas.
Data from two promising vaccine trials heralded potential breakthroughs in the treatment of pneumococcal infection and Lyme disease.
Early data this year suggests back-to-school season spending is either flat from last year, or took a slight dip.